CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

sac-TMT

Phase 3
MERCK (MRK)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
7mo
MRKPDUFA
Phase 3

FDA PDUFA Date sac-TMT (sacituzumab tirumotecan) (standard)

sac-TMT
Jun 15
SEC
00%
Drug Information

Target Indication

Non-small Cell Lung Cancer

Clinical Trial

NCT06422143

Last updated: 1/27/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.